Stoke Therapeutics CEO Edward M. Kaye Sells 42,350 Shares
| Reporter Name | Kaye Edward M. Md |
| Relationship | CEO |
| Type | Sell |
| Amount | $653,529 |
| SEC Filing | Form 4 |
Edward M. Kaye, CEO and Director of Stoke Therapeutics, sold 42,350 shares of common stock on May 20, 2024. The sales were conducted at weighted average prices of $15.3904 and $16.0457, with the total sale amounting to $653,529. Following these transactions, Kaye directly owns 27,000 shares of Stoke Therapeutics. The sales were executed under a Rule 10b5-1 trading plan adopted on December 26, 2023.
SEC Filing: Stoke Therapeutics, Inc. [ STOK ] - Form 4 - May. 22, 2024